The TB Europe Coalition (TBEC) is an advocacy network that brings together civil society representatives (individuals and organisations) from across the WHO European Region; in order to strengthen the role of civil society within the regional response to tuberculosis (TB), and to increase the political and financial commitment required to effectively control the epidemic in region. TBEC was formed by a group of TB advocates in 2009. They identified a need to capacitate and bring together civil society in order to address two major concerns: high-rates of drug resistance, coupled with low awareness among general populations and policy-makers about this problem. This was especially due to a scarcity of civil society stakeholders working on TB in the region, despite their important role within an effective response, with few capable of advocating for TB at national or regional level. TBEC addresses this by providing a coordinating body that brings together civil society stakeholders across the region, disseminates high-quality information and resources, promotes collaboration and best practice, and aims to build the advocacy capacity of civil society stakeholders working to control TB.


AIDS Action Europe (AAE) is a comprehensive NGO network in the field of HIV/AIDS with over 440 network members and partners from all over Europe and Central Asia. It is a unique player with substantial added value for European policy making and programme implementation.The leading principle of AIDS Action Europe’s multiannual Framework Partnership Agreement 2015 – 2017 is continuity and innovation. The programme described in this proposal will follow up on achievements since the start of AAE in 2004 and will extend its agenda with activities aimed at optimising the EU’s response to the HIV/AIDS epidemic and strengthening the AAE network. In the area of policy, AAE will keep its focus on the coordination of the EU Civil Society Forum on HIV/AIDS and on contributing to the EU Think Tank, so that the voices of AAE members and other members of civil society are heard.In the field of linking and learning, AAE will continue investing in its Clearinghouse, as a database for exchanging good practice and sharing information. Website, social media, newsletters and mailings will remain key means to disseminate news and information. AAE strives for innovation and is determined to improve communication, linking and learning, and exchange of good practice: - The Clearinghouse is of great value for AAE members and beyond; it will be re-launched in the coming project period. Its contents will be re-structured to intensify linking and learning. Furthermore, it will be transformed into an interactive platform for information and opinion exchange.- The AAE website will be re-designed in order to improve information distribution troughout the region.- The bilingual communication efforts will be intensified to reach member organisations in Russian speaking countries more effectively.- Consultancies, working groups and project development meetings will provide opportunities to address emerging issues at country, regional and European level and to stimulate European cooperation.


Proposal for annual OPG to support Europe's largest civil society public health network in core activities and actions in support of all of the objectives of the European Union 3rd Health Programme.

EPHA will contribute to the realisation of all four objectives of the 3HP; EPHA activities for the period 2018-2021 will contribute to 20 of the 23 thematic priorities in Annex I of Regulation 282/2014.

The overarching objective driving EPHA’s entire policy and advocacy effort is: To promote good health and well-being, to reduce disease and health inequalities in European policies and programmes.
Operationalised by two further strategic objectives:
- Public health objectives and the reduction of health inequalities will be taken into account (‘mainstreamed’) through all relevant EU policies and programmes, with the EU institutions making a shift to a Governance for Health approach.
- EPHA generates new ideas to protect and improve public health, reduce health inequalities and ensure universal access to good quality care in sustainable health systems, and anchors them with European policy-makers.

The aims are further supported by specific objectives, followed by activities, milestones, deliverables and impact indicators for each of the priority work areas selected by the membership:
1.Prevention of chronic, non-communicable Diseases (incl food and agriculture, alcohol, tobacco )
2.Universal Access to Affordable Medicines
3.Action on Antimicrobial Resistance
4.Inclusive Digital Health
5.Healthy Trade Policy
6.Improving access to health/care for vulnerable groups (incl Roma)
7.Financing Public Health
8.Capacity building & Organisational Development (incl Solidarity Corps)

EPHA’s approach systematically mainstreams key concerns across all of these areas, including tackling health inequalities and improving access to healthcare, specific issues including mental health, health workforce, data protection, integrative care, children and youth and gender equality.


“Stronger together” is the title of this proposal of AIDS Action Europe (AAE), a network of 415 NGOs, national networks, AIDS service organisations, and community based groups in 47 countries in the WHO European Region. The motto reflects the objective of AAE to join efforts, not only within the network but also with other stakeholders and partners in the response to HIV/AIDS, tuberculosis and viral hepatitis. In April 2017, the AAE Steering Committee decided to change its mission statement: The integrative approach, addressing not only HIV/AIDS but also tuberculosis and viral hepatitis as mono-infections, echoes the decision to use synergies and avoid duplications wherever and whenever possible. This applies in particular for key populations who are especially affected by and vulnerable to the three epidemics.
But “Stronger together” also stands for maintaining and improving collaboration and communication between partners in the 3rd Health programme in the field of HIV/AIDS, TB and viral hepatitis as well as for ensuring sustainability of materials and deliverables developed within the programme.
Considering the epidemiological background of the three diseases and AAE’s mission, vision and strategy and after consulting AAE Members and partners, the following six core thematic areas were identified to focus on in the upcoming four years:
- Community based voluntary counselling and testing (CBVCT)
- Affordability and accessibility to medicines
- Tackling legal barriers in the response to HIV, TB and hepatitis
- Criminalisation of HIV non-disclosure, exposure and transmission
- Sexual and reproductive health and rights (SRHR)
- Tackling stigma and discrimination
The three main objectives of the work are
- advocacy to strengthen Civil Society’s response to the three epidemics,
- providing platforms to communicate and facilitate collaboration, networking, and linking and learning
- and continuous improvement of network collaboration.



The Correlation Network (CN) is a European civil society network and centre of expertise in the field of drug use, harm reduction and social inclusion.

Overall objective of this proposal:
Improve the access to and the quality of harm reduction services for People Who Use Drugs (PWUD), including other related vulnerable and marginalised people and to enhance policies and practices that increase social inclusion.

This is achieved by the following strategic objectives
- Strengthen the network and the collaboration with its members and partners through an adequate and solid organisational network structure
- Monitor developments and collect information and evidence in the field of drug use and harm reduction, by involving the expertise of civil society organisations
- Strengthen capacities of the various players in the field of drug use and harm reduction and facilitate exchange between network members and partners
- Advocate for full coverage of harm reduction programmes in Europe, addressing both health and social aspects.

All CN activities will pay specific attention to Hepatitis C, new drug trends and drug patterns and overdose prevention. Relevant CN outputs include : Sustainable network, Annual Monitoring Reports, Online knowledge and training hub, European Harm Reduction Conferences (2018/20), policy recommendations.

CN contributes to the Third Health Programme (THP) by promoting health (in particular harm reduction), prevent diseases (in particular drug-related diseases and infectious diseases such as HCV and HIV/AIDS), and foster supportive environments for healthy lifestyles (e.g. by reducing barriers to access health and social services).

CN contributes as well to the following THP priorities:
1.2. Drugs-related health damage, including information and prevention
1.3. HIV/AIDS, tuberculosis and hepatitis
2.2. Capacity-building against health threats in Member States, including, where appropriate, cooperation with
neighbouring countries



